Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_assertion evidence source_evidence_literature NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_assertion SIO_000772 22334453 NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_assertion wasDerivedFrom befree-20140225 NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_assertion wasGeneratedBy ECO_0000203 NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP759200.RAlTOftxC5sw7FsinoHmM76seg5kaHZwdjxbn1bAB9A6c130_provenance.